Armistice Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Sell |
2,560,000
-208,000
| -8% | -$1.98M | 0.42% | 31 |
|
|
2025
Q1 | $29M | Buy |
2,768,000
+1,803,482
| +187% | +$18.9M | 0.43% | 43 |
|
|
2024
Q4 | $22.7M | Sell |
964,518
-190,686
| -17% | -$4.49M | 0.31% | 59 |
|
|
2024
Q3 | $41.5M | Buy |
1,155,204
+184,313
| +19% | +$6.62M | 0.66% | 27 |
|
|
2024
Q2 | $34.3M | Sell |
970,891
-29,109
| -3% | -$1.03M | 0.43% | 37 |
|
|
2024
Q1 | $28.4M | Buy |
1,000,000
+176,000
| +21% | +$5M | 0.38% | 40 |
|
|
2023
Q4 | $11M | Sell |
824,000
-376,000
| -31% | -$5M | 0.15% | 75 |
|
|
2023
Q3 | $10.8M | Buy |
1,200,000
+288,000
| +32% | +$2.58M | 0.16% | 79 |
|
|
2023
Q2 | $10.3M | Buy |
+912,000
| New | +$10.3M | 0.15% | 92 |
|